A 9L Gliosarcoma Transplantation Model for Studying Adoptive Immunotherapy into the Brains of Conscious Rats

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Cell Transplantation

• Publication date

  1992-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/096368979200100408PMID 1344303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.

  1990cited by this paper
• A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

  1987cited by this paper
• Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from "histologically normal" to that showing different levels of glial tumor involvement.

  1986cited by this paper
• Comparison of the effects of ventral medullary lesions on systemic and microinjection morphine analgesia.

  1984cited by this paper
• Immunogenetic and immunologic aspects of gliosarcoma growth in rats.

  1983cited by this paper
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

  1982cited by this paper
• Failure of spinal cord serotonin depletion to alter analgesia elicited from the periaqueductal gray.

  1982cited by this paper
• Viral DNA in transformed cells. II. A study of the sequences of adenovirus 2 DNA IN NINE LINES OF TRANSFORMED RAT CELLS USING SPECIFIC FRAGMENTS OF THE VIRAL GENOME;.

  1974cited by this paper
• Viral DNA in transformed cells. I. A study of the sequences of adenovirus 2 DNA in a line of transformed rat cells using specific fragments of the viral genome.

  1974cited by this paper

• Adoptive T Cell Therapies for Glioblastoma

  2016cites this paper
• Animal models for vaccine therapy.

  2012cites this paper
• Implementing preclinical study findings to protocol design: translational studies with alloreactive CTL for gliomas.

  2012cites this paper
• Development of FENSI (Flow Enhanced Signal Intensity) perfusion sequence and application to the characterization of microvascular flow dynamics using MRI

  2012cites this paper
• Immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes: downregulation of multiple proapoptotic factors.

  2008cites this paper
• Intracranial administrations of single or multiple source allogeneic cytotoxic T lymphocytes: chronic therapy for primary brain tumors

  2005cites this paper
• Glioma cell integrin expression and their interactions with integrin antagonists: Research Article.

  2005cites this paper
• A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: A comparison to 9L gliosarcoma

  2005cites this paper
• Rat brain tumor models in experimental neuro-oncology:The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 Gliomas

  2004cites this paper
• Microglia phagocytose alloreactive CTL-damaged 9L gliosarcoma cells.

  2004cites this paper
• Interactions of the allogeneic effector leukemic T cell line, TALL-104, with human malignant brain tumors.

  2004cites this paper
• γInterferon Transduced 9L Gliosarcoma. Cytokine Gene Therapy and its Relevance to Cellular Therapy with Alloreactive Cytotoxic T Lymphocytes

  2004cites this paper
• Gamma interferon transduced 9L gliosarcoma. Cytokine gene therapy and its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes.

  2003cites this paper
• γ Interferon transduced 9L gliosarcoma. Cytokine gene therapy and its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes

  2003cites this paper
• Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-gamma or IFN-gamma gene modification.

  2003cites this paper
• Human Alloreactive CTL Interactions with Gliomas and with Those Having Upregulated HLA Expression from Exogenous IFN-γ or IFN-γ Gene Modification

  2003cites this paper
• Characterization of 9L Glioma Model of the Wistar Rat

  2003cites this paper
• Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes.

  2002cites this paper
• Effects of IFN-γ and Interleukin-1β on Major Histocompatibility Complex Antigen and Intercellular Adhesion Molecule-1 Expression by 9L Gliosarcoma: Relevance to Its Cytolysis by Alloreactive Cytotoxic T Lymphocytes

  2002cites this paper
• Immunologic approaches to therapy for brain tumors

  2001cites this paper
• Cytotoxic T-Lymphocytes Reactive to Patient Major Histocompatibility Complex Proteins for Therapy of Brain Tumors

  2001cites this paper
• Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy.

  2000cites this paper
• Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma

  2000cites this paper
• Tissue : Implications for Local Adoptive Immunotherapy Human Malignant Brain Tumors and Traffics through Brain The Human Leukemic T-Cell Line , TALL-104 , Is Cytotoxic to Updated

  2000cites this paper
• The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: implications for local adoptive immunotherapy.

  2000cites this paper
• Morphometrical Characterization of Two Glioma Models in the Brain of Immunocompetent and Immunodeficient Rats

  1999cites this paper
• Rat Brain Tumor Models and the Statistical Evaluation of Survival Data in Experimental Neuro-Oncology

  1998cites this paper
• Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2

  1997cites this paper
• Migration of activated lymphocytes when adoptively transferred into cannulated rat brain.

  1994cites this paper